XCL1 potently inhibited HIV-1 infection irrespective of coreceptor specificity, as it was equally effective on strains specific for CXCR4 (X4; IIIB) and CCR5 (R5; BaL) (Figure 2A). This evidence concerns the gene CXCR4 and HIV-1 infection.